Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Or Sell Monsanto Company (MON) Following Mixed Results?

When looking at the hedgies followed by Insider Monkey, Glenview Capital, managed by Larry Robbins, holds the number one position in Monsanto Company (NYSE:MON), with a $1.09 billion stake that contained 9.69 million shares by the end of the first quarter. This stake comprised 5% of Glenview Capital’s 13F portfolio. D E Shaw, managed by David E. Shaw, came in second as it held a $365.2 million position. Some other peers that hold long positions include Alan Fournier’s Pennant Capital Management, Jeffrey Tannenbaum’s Fir Tree and Jonathon Jacobson’s Highfields Capital Management.

Judging by the fact that Monsanto Company (NYSE:MON) has witnessed some bearish sentiment from hedge fund managers, it’s easy to see that there is a number of money managers that elected to cut their positions entirely heading into the second quarter. Intriguingly, Keith Meister‘s Corvex Capital sold out the largest investment among all the hedge funds tracked by Insider Monkey after dumping about 2.42 million shares of Monsanto Company. Benjamin A. Smith’s fund, Laurion Capital Management, also closed its position, which contained 1.0 million shares.

Given the drop in hedge fund interest and unchanged insider sentiment coupled with the mixed result for its third quarter for the fiscal year 2015, Monsanto Company (NYSE:MON) does not seem to be a good buy for now.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.